Gilead Sciences Announces Second Quarter 2023 Financial Results

Gilead Sciences Announces Second Quarter 2023 Financial Results.

Gilead Sciences Announces Second Quarter 2024 Financial Results

Total second quarter 2024 product sales increased 5% to $6.9 billion, compared to the same period in 2023. Total product sales, excluding ...

Gilead Sciences to Release Second Quarter 2023 Financial Results ...

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its second quarter 2023 financial results ...

Gilead Sciences Announces Second Quarter 2023 Financial Results

Gilead Sciences, Inc. announced today its results of operations for the second quarter of 2023.. Total second quarter 2023 revenue increased ...

Gilead Sciences to Release Second Quarter 2023 Financial Results ...

Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its second quarter 2023 financial results and guidance will be released on ...

Gilead Sciences Announces Third Quarter 2024 Financial Results

Total third quarter 2024 revenue increased 7% to $7.5 billion compared to the same period in 2023, primarily due to higher sales in HIV as well ...

Financials - Quarterly Results - Gilead Sciences, Inc.

Financial Summary Table · 2024 · Q1 · Q2 · Q3 · 2023 · Q1 · Q2 · Q3.

Gilead Sciences Announces Second Quarter 2024 Financial Results

Total second quarter 2024 revenue increased 5% to $7.0 billion , compared to the same period in 2023, primarily due to higher product sales in ...

Gilead Sciences Announces Fourth Quarter and Full Year 2023 ...

The company's Board of Directors declared a quarterly dividend of $0.77 per share of common stock for the first quarter of 2024. The dividend is ...

Gilead Sciences Announces Third Quarter 2024 Financial Results

Total third quarter 2024 revenue increased 7% to $7.5 billion compared to the same period in 2023, primarily due to higher sales in HIV as well ...

Gilead Sciences Announces Fourth Quarter and Full Year 2023 ...

Gilead Sciences, Inc. announced today its results of operations for the fourth quarter and full year 2023.. We are expecting several ...

Gilead Sciences Reports Q2 2024 Financial Results

Gilead Sciences, Inc. announced its financial results for the second quarter ... 2023. This boost was primarily driven by heightened sales ...

Gilead Sciences reports net income rise in Q2 2024

The company's total product sales for the quarter saw a 5% increase to $6.9bn, compared to $6.5bn in the second quarter of 2023. Excluding sales ...

Merck Announces Third-Quarter 2024 Financial Results

In the third quarter of 2024, total worldwide sales were $16.7 billion, an increase of 4% compared with the third quarter of 2023; excluding the ...

gilead sciences announces fourth quarter and full year 2021 ...

Trodelvy sales for the fourth quarter 2021 were $118 million, reflecting continued uptake in the second-line setting for treatment of metastatic triple-negative ...

GILEAD SCIENCES, INC. - cloudfront.net

GILEAD SCIENCES ANNOUNCES SECOND QUARTER 2024 FINANCIAL RESULTS ... second quarter 2024 and in the same period in 2023. Non-GAAP. R&D ...

gilead sciences announces first quarter 2024 financial results

Total first quarter 2024 revenue increased 5% to $6.7 billion, compared to the same period in 2023, primarily due to higher HIV, Oncology and ...

Merus Announces Financial Results for the Second Quarter 2024 ...

We ended the second quarter with cash, cash equivalents and marketable securities of $846.4 million compared to $411.7 million at December 31, ...

Merck Announces Second-Quarter 2024 Financial Results

Total Worldwide Sales Were $16.1 Billion, an Increase of 7% From Second Quarter 2023; Excluding the Impact of Foreign Exchange, Growth Was 11% ...

Gilead Sciences announces third quarter financial results - OncoDaily

We're on track to submit for FDA approval by the end of the year, with a commercial launch planned for 2025. Another highlight for the third ...